Studies on β-d-Galf -(1→4)-α-l-Rhap octyl analogues as substrates for mycobacterial galactosyl transferase activity Original Research Article

The biochemically unique structures of sugar residues in the outer cell wall of Mycobacterium tuberculosis (MTB) make the pathways for their biosynthesis and utilization attractive targets for the development of new and selective anti-tubercular agents. A cell-free assay system for galactosyltransferase activity using UDP[14C]Gal as the glycosyl donor, as well as an in vitro colorimetric broth micro-dilution assay system, were used to determine the activities of three β-d-galf(1→4)-α-l-rhamp octyl disaccharides as substrates and antimycobacterial agents respectively. The cell-free enzymatic studies using compounds and suggested that these disaccharides bind to and are effective substrates for a putative mycobacterial galactosyltransferase. The modified acceptor was found to be a slower but prolonged binder as compared to the less substituted analogue as evidenced by their Km and Vmax values. Moderate antimycobacterial activity was observed with compounds and against MTB H37Ra and three clinical isolates of Mycobacterium avium complex (MAC).